Individualising insulin options in type 2 diabetes: From initiation to intensification

You need to login to participate in this education.

Please log in, or if you don't already have a free account, register to continue.

This education is accredited: RACGP 2 CPD, ACRRM 1 CME PD.

Insulin therapy is a key part of glycaemic management in type 2 diabetes, and individualised treatment is central to providing optimal outcomes. This module outlines the tailored selection of insulin regimens for initiation and intensification, and the effective use of education and review to provide ongoing care.

Upon completion of this module the participant should be able to:

  • Outline the types of insulin and their different profiles of action.
  • Implement a structured approach to initiating and intensifying insulin in type 2 diabetes (T2D).
  • Describe how to individualise insulin options for the individual with T2D.
  • Rationalise when second-generation insulins can be considered in people with T2D requiring insulin therapy.

If you are an Australian GP and wish to undertake a quality improvement activity on this topic, the IN Control clinical audit is also available.

This activity is sponsored by Novo Nordisk.

Content partners: 
Individualising insulin options in type 2 diabetes - Education
Individualising insulin options in type 2 diabetes - Evaluation